{"id":759031,"date":"2026-06-25T09:08:15","date_gmt":"2026-06-25T09:08:15","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/759031\/"},"modified":"2026-06-25T09:08:15","modified_gmt":"2026-06-25T09:08:15","slug":"pro-medicus-shares-jump-again-as-ai-deal-adds-fuel-to-40-rally","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/759031\/","title":{"rendered":"Pro Medicus shares jump again as AI deal adds fuel to 40% rally"},"content":{"rendered":"\n<p>Pro Medicus Ltd\u00a0(<a class=\"tickerized-link\" href=\"https:\/\/www.fool.com.au\/tickers\/asx-pme\/\" rel=\"nofollow noopener\" target=\"_blank\">ASX: PME<\/a>) shares are having another strong session on Thursday as investors continue to buy back into the ASX healthcare stock. <\/p>\n<p>At the time of writing, the Pro Medicus share price is up 2.05% to $182.66. <\/p>\n<p>It has been a big month for the company&#8217;s shares, which have now climbed around 40% over that period.<\/p>\n<p>That bounce has helped repair some of the damage from earlier in the year. Even after the recent rally, Pro Medicus shares are still down roughly 17% since the start of 2026. <\/p>\n<p>The latest announcement appears to have given the rally another push.<\/p>\n<p> <img fetchpriority=\"high\" decoding=\"async\" width=\"1200\" height=\"675\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/09\/div-1200x675.jpg\" class=\"attachment-full size-full wp-post-image\" alt=\"A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.\"  \/><\/p>\n<p>Image source: Getty Images<\/p>\n<p> Pro Medicus signs AI agreement <\/p>\n<p>According to the\u00a0<a href=\"https:\/\/www.fool.com.au\/tickers\/asx-pme\/announcements\/2026-06-25\/3a695944\/pme-signs-hoa-echo-iq-finance-facility-reseller-agreement\/\" rel=\"nofollow noopener\" target=\"_blank\">release<\/a>, Pro Medicus has signed binding heads of agreement (HoA) with\u00a0Echo IQ Ltd (<a class=\"tickerized-link\" href=\"https:\/\/www.fool.com.au\/tickers\/asx-eiq\/\" rel=\"nofollow noopener\" target=\"_blank\">ASX: EIQ<\/a>).<\/p>\n<p>The deal would see Pro Medicus take a stake in Echo IQ and work with the company to sell its products in the US. <\/p>\n<p>Echo IQ is an AI and medical technology company working in cardiology. Its software is designed to help doctors make decisions using heart imaging data.<\/p>\n<p>Under the agreement, Pro Medicus will make an initial $10 million investment in Echo IQ through secured convertible notes.<\/p>\n<p>There is also room for another $10 million investment if Echo IQ receives US Food and Drug Administration clearance for its EchoSolv HF product. <\/p>\n<p>EchoSolv HF is an AI-powered tool that helps identify heart failure risk using cardiac imaging data.<\/p>\n<p>Furthermore, the agreement includes a proposed reseller arrangement. This allows Pro Medicus to market and distribute Echo IQ&#8217;s products to its healthcare customers, particularly in the United States. <\/p>\n<p> Echo IQ deal opens another door <\/p>\n<p>The update seems to have gone down well because it gives Pro Medicus another way to build out its cardiology offering.<\/p>\n<p>The company is already best known for its Visage Imaging platform, which is used by large healthcare groups to view and manage medical images. <\/p>\n<p>This agreement could add Echo IQ&#8217;s AI technology to the mix, while giving Echo IQ access to a much larger customer network.<\/p>\n<p>Pro Medicus CEO Dr Sam Hupert said the company is &#8220;looking to offer Visage 7 Cardiology customers the option of using Echo IQ&#8217;s technology.&#8221;<\/p>\n<p>He said the agreement fits with the company&#8217;s strategy of offering a carefully selected suite of algorithms. That includes its own technology, tools created with clinical partners, and third-party algorithms such as Echo IQ.<\/p>\n<p> What comes next? <\/p>\n<p>It&#8217;s worth remembering that despite the positive news, the agreement still needs final legal documentation.<\/p>\n<p>The companies said the deal is expected to be finalised in the coming weeks.<\/p>\n<p>Echo IQ also said its FDA submission for EchoSolv HF remains on track for an outcome in the near term.<\/p>\n","protected":false},"excerpt":{"rendered":"Pro Medicus Ltd\u00a0(ASX: PME) shares are having another strong session on Thursday as investors continue to buy back&hellip;\n","protected":false},"author":2,"featured_media":127614,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[256,254,255,64,63,105],"class_list":["post-759031","post","type-post","status-publish","format-standard","has-post-thumbnail","category-artificial-intelligence","tag-ai","tag-artificial-intelligence","tag-artificialintelligence","tag-au","tag-australia","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/759031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=759031"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/759031\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/127614"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=759031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=759031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=759031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}